To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CDT1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
255 supporting clones for gene CDT1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AW327360 blood, T cell leukemia .a 1 to 528 9 to 536   tiling clone,   528/616
(85 %)
3 diff
(99.6 %id)
CN271899 embryonic stem cells, DMSO-treated H9 cellline .a 524 to 710 1 to 187   tiling clone,   187/187
(100 %)
4 diff
(97.9 %id)
BU158281 eye, retinoblastoma .a 553 to 1393 1 to 844       842/854
(98 %)
16 diff
(98.2 %id)
AB053172   .a 558 to 3231 1 to 2674 C234R T262A AAA   2674/2674
(100 %)
5 diff
(99.9 %id)
NM_030928.3   .a 558 to 3231 1 to 2674 exact RefSeq, AAA   2674/2674
(100 %)
0 diff
(100 %id)
AL560057 B cells (Ramos cell line), B cells from Burkitt lymphoma .a 570 to 1110 56 to 601       546/888
(61 %)
49 diff
(94.5 %id)
BM452773 lymph, lymphoma, cell line .a 580 to 1137 1 to 560       560/916
(61 %)
7 diff
(99.3 %id)
CR600099 T cells (Jurkat cell line) Cot10-normalized .a 582 to 2428 1 to 1847 exact     1847/1847
(100 %)
0 diff
(100 %id)
AL558613 T cells from T cell leukemia .a 582 to 1517 1 to 933   fully sequenced,   933/933
(100 %)
10 diff
(99.0 %id)
BM463356 embryonal carcinoma, cell line, testis .a 582 to 1400 1 to 819       819/950
(86 %)
12 diff
(98.8 %id)
BM741796 stomach .a 584 to 1069 1 to 486       486/486
(100 %)
3 diff
(99.4 %id)
BM783362 stomach .a 584 to 1188 1 to 605       605/605
(100 %)
0 diff
(100 %id)
BM783379 stomach .a 584 to 1141 1 to 558       558/558
(100 %)
0 diff
(100 %id)
BM783501 stomach .a 584 to 1243 1 to 660       660/660
(100 %)
0 diff
(100 %id)
BM758710 Ascites, stomach .a 584 to 1245 1 to 662       662/662
(100 %)
0 diff
(100 %id)
BM563094 astrocytoma grade IV, cell line, brain .a 585 to 1276 1 to 701       701/1064
(65 %)
29 diff
(97.3 %id)
BQ214117 embryonal carcinoma, cell line, testis .a 586 to 1102 1 to 524       524/1053
(49 %)
14 diff
(98.7 %id)
CR603023 neuroblastoma .a 587 to 2454 1 to 1868 exact     1868/1868
(100 %)
0 diff
(100 %id)
AL518300 brain, neuroblastoma, neuroblastoma cells .a 587 to 1514 1 to 927   fully sequenced,   927/927
(100 %)
14 diff
(98.5 %id)
BM543383 embryonal carcinoma, cell line, testis .a 587 to 1004 1 to 418       418/1369
(30 %)
4 diff
(99.8 %id)
BQ057127 lymph, lymphoma, cell line .a 587 to 1100 1 to 516       516/1129
(45 %)
21 diff
(98.2 %id)
CR597956 Neuroblastoma Cot 10-normalized .a 589 to 2470 1 to 1882 exact tiling clone,   1882/1882
(100 %)
0 diff
(100 %id)
AL520240 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 589 to 1537 1 to 949   fully sequenced,   949/949
(100 %)
1 diff
(99.9 %id)
BQ232213 melanotic melanoma, skin .a 590 to 1100 1 to 516       516/1269
(40 %)
10 diff
(99.3 %id)
CR613446 T cells (Jurkat cell line) Cot10-normalized .a 591 to 2430 1 to 1840 exact     1840/1840
(100 %)
0 diff
(100 %id)
AF321125   .a 592 to 2483 6 to 1897 C234R T262A AAA   1892/1897
(99 %)
11 diff
(99.5 %id)
AL556319 placenta .a 592 to 1532 1 to 943       943/943
(100 %)
4 diff
(99.6 %id)
BE018212 cervical carcinoma cell line, cervix .a 592 to 1035 6 to 449       444/449
(98 %)
6 diff
(98.7 %id)
BM541470 leiomyosarcoma, uterus .a 594 to 1213 25 to 650       626/1225
(51 %)
25 diff
(98.0 %id)
BU164998 eye, retinoblastoma .a 594 to 1443 11 to 876       866/977
(88 %)
42 diff
(95.8 %id)
BU957101 adenocarcinoma, cell line, breast .a 594 to 961 10 to 377       368/1207
(30 %)
10 diff
(99.2 %id)
AL559054 T cells from T cell leukemia .a 595 to 1513 3 to 920   fully sequenced,   918/920
(99 %)
12 diff
(98.7 %id)
BM469168 embryonal carcinoma, cell line, testis .a 595 to 1238 90 to 738       649/1213
(53 %)
21 diff
(98.3 %id)
BC000137 Cervix, carcinoma .a 596 to 3231 1 to 2636 C234R tiling clone, available from MGC, AAA   2636/2636
(100 %)
4 diff
(99.9 %id)
BU846504 ovary, teratocarcinoma, cell line .a 596 to 1044 25 to 473       449/1025
(43 %)
10 diff
(99.1 %id)
AL527292 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 598 to 921 5 to 328       324/351
(92 %)
9 diff
(97.5 %id)
BM552135 leiomyosarcoma, uterus .a 598 to 1373 1 to 780       778/1044
(74 %)
17 diff
(98.4 %id)
BU859159 ovary, teratocarcinoma, cell line .a 598 to 1444 1 to 859       859/923
(93 %)
15 diff
(98.4 %id)
BQ431265 embryonal carcinoma, cell line, testis .a 599 to 1151 1 to 554       554/561
(98 %)
7 diff
(98.8 %id)
BU522023 leiomyosarcoma, uterus .a 599 to 1344 1 to 754       752/885
(84 %)
10 diff
(98.9 %id)
BM742987 stomach .a 599 to 1008 1 to 414       414/414
(100 %)
11 diff
(97.4 %id)
CR598796 Neuroblastoma Cot 25-normalized .a 600 to 2435 1 to 1836 exact     1836/1836
(100 %)
0 diff
(100 %id)
AL524910 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 600 to 1474 1 to 874   fully sequenced,   874/874
(100 %)
17 diff
(98.1 %id)
BU176676 eye, retinoblastoma .a 601 to 1443 1 to 851       851/878
(96 %)
20 diff
(97.8 %id)
BC009410 Uterus, endometrium adenocarcinoma .a 602 to 2483 1 to 1882 C234R available from MGC, AAA   1882/1882
(100 %)
1 diff
(100.0 %id)
BQ647648 hepatocellular carcinoma, cell line, Liver .a 603 to 1217 1 to 622       622/1010
(61 %)
17 diff
(98.4 %id)
DR761279 embryonic stem .a 604 to 1356 1 to 753       753/753
(100 %)
1 diff
(99.9 %id)
CR609788 HeLa cells Cot 25-normalized .a 605 to 2433 1 to 1829 exact     1829/1829
(100 %)
0 diff
(100 %id)
AL520888 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 605 to 1473 1 to 864       864/864
(100 %)
38 diff
(95.7 %id)
BX421258 B cells (Ramos cell line) .a 605 to 1632 1 to 1022       1023/1022
(100 %)
12 diff
(98.9 %id)
AL555432 placenta .a 605 to 1539 1 to 934   fully sequenced,   934/934
(100 %)
11 diff
(98.9 %id)
BU164161 embryonal carcinoma, cell line, testis .a 605 to 1443 1 to 847       847/913
(92 %)
23 diff
(97.5 %id)
AL557066 T cells (Jurkat cell line), T cells from T cell leukemia .a 606 to 1633 1 to 1021       1021/1030
(99 %)
15 diff
(98.6 %id)
AL515464 brain, neuroblastoma, neuroblastoma cells .a 607 to 1442 1 to 832       832/995
(83 %)
16 diff
(98.4 %id)
BM913265 amelanotic melanoma, cell line, skin .a 607 to 1099 1 to 493       493/1142
(43 %)
5 diff
(99.6 %id)
BU850159 ovary, teratocarcinoma, cell line .a 607 to 1168 1 to 562       562/943
(59 %)
1 diff
(99.9 %id)
BU932050 ovary, teratocarcinoma, cell line .a 610 to 1187 1 to 582       582/1224
(47 %)
39 diff
(96.9 %id)
CR625627 B cells (Ramos cell line) Cot 25-normalized .a 616 to 2426 1 to 1811       1811/1811
(100 %)
0 diff
(100 %id)
AL582018 B cells from Burkitt lymphoma .a 616 to 1538 1 to 919   fully sequenced,   919/919
(100 %)
10 diff
(99.0 %id)
BM450908 eye, retinoblastoma .a 616 to 1426 1 to 824       824/902
(91 %)
24 diff
(97.4 %id)
BM927844 hepatocellular carcinoma, cell line, Liver .a 616 to 1438 1 to 828       828/1039
(79 %)
13 diff
(98.8 %id)
BU931060 ovary, teratocarcinoma, cell line .a 630 to 1425 10 to 813       804/920
(87 %)
25 diff
(97.3 %id)
AL516574 brain, neuroblastoma, neuroblastoma cells .a 643 to 1270 1 to 628       628/628
(100 %)
5 diff
(99.3 %id)
BX333703 Neuroblastoma Cot 25-normalized .a 664 to 1708 14 to 1047       1034/1055
(98 %)
44 diff
(95.9 %id)
BC008860 Brain, neuroblastoma .a 665 to 3231 1 to 2570   available from MGC, AAA   2570/2570
(100 %)
13 diff
(99.5 %id)
BF317465 brain, neuroblastoma .a 702 to 1356 1 to 637   available from MGC,   637/819
(77 %)
26 diff
(96.9 %id)
BQ225271 epithelioid carcinoma, Pancreas .a 719 to 1148 1 to 435       435/1098
(39 %)
14 diff
(98.8 %id)
BC008676 Eye, retinoblastoma .a 720 to 2483 1 to 1764   available from MGC, AAA   1764/1764
(100 %)
5 diff
(99.8 %id)
DN997120 breast cancer, Mammary gland (cancer tissue) .a 737 to 1313 9 to 585       577/585
(98 %)
7 diff
(98.9 %id)
BE779415 eye, retinoblastoma .a 743 to 1440 1 to 689   available from MGC,   661/800
(82 %)
66 diff
(91.8 %id)
BQ422630 embryonal carcinoma, cell line, testis .a 786 to 1298 12 to 525       514/1029
(49 %)
20 diff
(98.1 %id)
BG472971 eye, retinoblastoma .a 810 to 1099 1 to 299       297/300
(99 %)
24 diff
(92.0 %id)
BY799495 eye .a 835 to 1393 1 to 559       559/559
(100 %)
3 diff
(99.5 %id)
BX464575 B cells (Ramos cell line) .a 838 to 1417 223 to 802       580/654
(88 %)
19 diff
(97.1 %id)
CR735560 blood, natural killer cells, cell line .a 859 to 1360 38 to 539       502/539
(93 %)
7 diff
(98.8 %id)
BM917547 blood, natural killer cells, cell line .a 862 to 1733 1 to 880       880/1086
(81 %)
29 diff
(97.4 %id)
BQ053069 blood, natural killer cells, cell line .a 862 to 1653 1 to 808       808/975
(82 %)
32 diff
(96.8 %id)
BQ053108 blood, natural killer cells, cell line .a 862 to 1734 1 to 889       889/1040
(85 %)
25 diff
(97.6 %id)
BQ053124 blood, natural killer cells, cell line .a 862 to 1623 1 to 770       768/929
(82 %)
19 diff
(98.0 %id)
BQ935210 brain, neuroblastoma, cell line .a 869 to 1787 1 to 920       920/927
(99 %)
7 diff
(99.3 %id)
BE778380 eye, retinoblastoma .a 880 to 1440 1 to 561       561/561
(100 %)
2 diff
(99.7 %id)
BE544515 cervical carcinoma cell line, cervix .a 926 to 1545 1 to 620       620/822
(75 %)
11 diff
(98.7 %id)
BC049205 Liver, adenocarcinoma .a 954 to 2483 1 to 1530   available from MGC, AAA   1530/1530
(100 %)
5 diff
(99.7 %id)
BI850728 adenocarcinoma, cell line, Liver .a 954 to 1441 1 to 489   available from MGC,   489/658
(74 %)
4 diff
(99.4 %id)
BG121275 adenocarcinoma, cell line, Liver .a 955 to 1656 1 to 702   available from MGC,   703/830
(84 %)
38 diff
(95.5 %id)
BI260243 cervical carcinoma cell line, cervix .a 960 to 1662 1 to 704       704/707
(99 %)
16 diff
(97.8 %id)
BU845736 ovary, teratocarcinoma, cell line .a 963 to 1743 1 to 783       783/925
(84 %)
14 diff
(98.5 %id)
BQ058496 lymph, lymphoma, cell line .a 970 to 1730 1 to 762       762/1049
(72 %)
12 diff
(98.9 %id)
BI335580 cervical carcinoma cell line, cervix .a 990 to 1736 26 to 769       744/850
(87 %)
19 diff
(97.8 %id)
BI333817 cervical carcinoma cell line, cervix .a 990 to 1660 1 to 673       673/673
(100 %)
8 diff
(98.9 %id)
CR610728 Neuroblastoma Cot 25-normalized .a 991 to 2454 1 to 1464       1464/1464
(100 %)
0 diff
(100 %id)
BX332414 Neuroblastoma Cot 25-normalized .a 991 to 1764 1 to 773   fully sequenced,   773/773
(100 %)
1 diff
(99.9 %id)
BM910749 astrocytoma grade IV, cell line, brain .a 1014 to 1545 1 to 532       532/1128
(47 %)
16 diff
(98.6 %id)
AF070552 brain .a 1017 to 2483 1 to 1465   AAA   1467/1465
(100 %)
9 diff
(99.4 %id)
T80294 whole brain .a 1019 to 1432 1 to 414       414/416
(99 %)
30 diff
(92.8 %id)
BF237902 leiomyosarcoma cell line, uterus .a 1025 to 1731 1 to 701       701/701
(100 %)
25 diff
(96.5 %id)
BF972427 leiomyosarcoma cell line, uterus .a 1025 to 1736 1 to 709   available from MGC,   709/1039
(68 %)
23 diff
(97.8 %id)
BC021126 Uterus, leiomyosarcoma .a 1026 to 2483 1 to 1458   available from MGC, AAA   1458/1458
(100 %)
4 diff
(99.8 %id)
BG824304 adenocarcinoma cell line, colon .a 1030 to 1958 1 to 921       921/972
(94 %)
40 diff
(95.9 %id)
BI093258 cervix .a 1030 to 1697 1 to 668       668/670
(99 %)
4 diff
(99.5 %id)
BM016975 astrocytoma grade IV, cell line, brain .a 1105 to 1886 1 to 781       781/787
(99 %)
9 diff
(98.9 %id)
BM019024 astrocytoma grade IV, cell line, brain .a 1105 to 1870 1 to 764       764/764
(100 %)
7 diff
(99.1 %id)
TI_59387214   .a 1106 to 1886 98 to 877       780/786
(99 %)
8 diff
(99.0 %id)
TI_59389702   .a 1106 to 1870 63 to 825       763/763
(100 %)
6 diff
(99.3 %id)
BU930971 ovary, teratocarcinoma, cell line .a 1113 to 1967 1 to 864       864/950
(90 %)
20 diff
(97.9 %id)
BU931977 ovary, teratocarcinoma, cell line .a 1113 to 2036 1 to 925       925/925
(100 %)
15 diff
(98.4 %id)
BQ062875 lymph, lymphoma, cell line .a 1136 to 2089 33 to 986       954/1054
(90 %)
34 diff
(96.8 %id)
BI092793 cervix .a 1161 to 1935 1 to 779       779/782
(99 %)
14 diff
(98.3 %id)
BX283173 astrocytoma grade IV, cell line, brain .a 1179 to 1686 1 to 508       508/508
(100 %)
3 diff
(99.5 %id)
BM811548 astrocytoma grade IV, cell line, brain .a 1182 to 2086 27 to 932       906/1055
(85 %)
16 diff
(98.5 %id)
BI258203 cervical carcinoma cell line, cervix .a 1187 to 1952 1 to 768       768/904
(84 %)
12 diff
(98.7 %id)
BG015220 placenta_normal .a 1200 to 1645 446 to 1       446/446
(100 %)
16 diff
(96.5 %id)
BG389325 embryonal carcinoma, cell line, testis .a 1200 to 1886 1 to 673       673/709
(94 %)
12 diff
(98.4 %id)
BI335105 cervical carcinoma cell line, cervix .a 1209 to 1926 1 to 716       716/716
(100 %)
8 diff
(98.9 %id)
BF818293 colon_ins .a 1210 to 1621 414 to 1     Submitted on the opposite strand 414/414
(100 %)
8 diff
(98.1 %id)
AA158647 Pancreas .a 1238 to 1430 1 to 192       192/194
(98 %)
6 diff
(97.0 %id)
BQ960305 leiomyosarcoma, uterus .a 1240 to 2030 1 to 792       792/927
(85 %)
11 diff
(98.9 %id)
BU187852 eye, retinoblastoma .a 1246 to 2146 1 to 907       907/907
(100 %)
25 diff
(97.3 %id)
CN368713 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1273 to 1843 1 to 571       571/571
(100 %)
4 diff
(99.3 %id)
BU849056 ovary, teratocarcinoma, cell line .a 1283 to 2178 1 to 900       900/904
(99 %)
11 diff
(98.8 %id)
CN368712 embryonic stem cells, cell lines H1, H7, andH9 .a 1285 to 1922 1 to 638       638/638
(100 %)
5 diff
(99.3 %id)
BG744520 blood, natural killer cells, cell line .a 1292 to 1786 1 to 495   fully sequenced,   495/495
(100 %)
4 diff
(99.2 %id)
BQ278148 ovary, teratocarcinoma, cell line .a 1295 to 2193 12 to 923       912/1056
(86 %)
32 diff
(97.0 %id)
BC014202 Kidney, renal cell adenocarcinoma .a 1298 to 2483 1 to 1187   available from MGC, AAA   1187/1187
(100 %)
6 diff
(99.5 %id)
BG327660 Kidney, renal cell adenocarcinoma .a 1298 to 2015 1 to 718   available from MGC,   718/718
(100 %)
9 diff
(98.8 %id)
BQ053758 blood, natural killer cells, cell line .a 1311 to 2281 1 to 985       985/988
(99 %)
33 diff
(96.7 %id)
BG259986 bladder, transitional cell papilloma, cell line .a 1350 to 2089 1 to 745       745/1150
(64 %)
9 diff
(99.3 %id)
BE727635 melanotic melanoma, skin .a 1367 to 2095 1 to 730       730/975
(74 %)
25 diff
(97.5 %id)
BG393757 embryonal carcinoma, cell line, testis .a 1406 to 2229 1 to 824       824/824
(100 %)
17 diff
(98.0 %id)
BG110061 Bone, osteosarcoma, cell line .a 1411 to 1949 13 to 552       540/571
(94 %)
10 diff
(98.3 %id)
AL524909 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 1413 to 2423 1017 to 13   fully sequenced,   1005/1017
(98 %)
18 diff
(98.3 %id)
BX402195 Neuroblastoma Cot 25-normalized .a 1413 to 2431 1027 to 10       1018/1027
(99 %)
6 diff
(99.5 %id)
BX406047 fetal liver, Liver .a 1413 to 2308 1 to 894       894/894
(100 %)
7 diff
(99.3 %id)
BI224536 cervical carcinoma cell line, cervix .a 1415 to 2399 46 to 783       738/783
(94 %)
14 diff
(98.3 %id)
BM800496 leiomyosarcoma, uterus .a 1423 to 2051 1 to 629       629/1142
(55 %)
20 diff
(98.3 %id)
BF791881 adrenal cortex carcinoma, cell line, adrenal gland .a 1442 to 2339 1 to 897       897/978
(91 %)
42 diff
(95.8 %id)
AL527465 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 1443 to 2455 1007 to 1       1007/1102
(91 %)
26 diff
(97.7 %id)
AL515463 brain, neuroblastoma, neuroblastoma cells .a 1450 to 2405 952 to 1       952/960
(99 %)
26 diff
(97.3 %id)
BU190377 melanotic melanoma, cell line, skin .a 1458 to 2332 1 to 886       886/895
(98 %)
23 diff
(97.5 %id)
BX447501 B cells (Ramos cell line) .a 1459 to 2418 952 to 1       954/953
(100 %)
87 diff
(90.9 %id)
BE910713 epithelioid carcinoma, Pancreas .a 1469 to 2147 1 to 677       677/922
(73 %)
10 diff
(99.0 %id)
BG822442 adenocarcinoma cell line, colon .a 1474 to 2143 1 to 677       677/804
(84 %)
10 diff
(98.8 %id)
AL580756 T cells from T cell leukemia .a 1483 to 2430 945 to 1   fully sequenced,   945/945
(100 %)
8 diff
(99.2 %id)
AL518299 brain, neuroblastoma, neuroblastoma cells .a 1484 to 2454 961 to 1   fully sequenced,   961/961
(100 %)
27 diff
(97.2 %id)
AL580393 T cells from T cell leukemia .a 1487 to 2428 935 to 1   fully sequenced,   935/935
(100 %)
7 diff
(99.3 %id)
CN368715 embryonic stem cells, DMSO-treated H9 cellline .a 1491 to 1938 7 to 454       448/454
(98 %)
1 diff
(99.8 %id)
BM917445 blood, natural killer cells, cell line .a 1496 to 2064 1 to 569       569/1301
(43 %)
5 diff
(99.7 %id)
AL520239 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 1507 to 2470 966 to 1   fully sequenced,   966/966
(100 %)
16 diff
(98.4 %id)
AL581992 B cells from Burkitt lymphoma .a 1508 to 2417 915 to 10   fully sequenced,   906/915
(99 %)
3 diff
(99.7 %id)
BG251456 adenocarcinoma, cell line, Liver .a 1508 to 2295 1 to 789       789/1113
(70 %)
28 diff
(97.5 %id)
AL577935 placenta .a 1514 to 2344 916 to 87   fully sequenced,   830/916
(90 %)
9 diff
(99.1 %id)
BU856820 adenocarcinoma, cell line, breast .a 1523 to 2366 1 to 854       854/943
(90 %)
23 diff
(97.6 %id)
BI222927 cervical carcinoma cell line, cervix .a 1539 to 2374 1 to 831       831/881
(94 %)
20 diff
(97.8 %id)
TI_159698516   .a 1539 to 2465 983 to 61       923/1102
(83 %)
25 diff
(97.8 %id)
BX427847 fetal liver, Liver .a 1542 to 2435 890 to 1       890/891
(99 %)
40 diff
(95.6 %id)
BM556535 amelanotic melanoma, cell line, skin .a 1543 to 2281 1 to 741       741/956
(77 %)
6 diff
(99.4 %id)
BM809482 amelanotic melanoma, cell line, skin .a 1544 to 2127 1 to 580       580/645
(89 %)
10 diff
(98.5 %id)
AL520887 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 1545 to 2462 916 to 1       916/916
(100 %)
16 diff
(98.3 %id)
BX283422 lymph, lymphoma, cell line .a 1552 to 2028 1 to 477       477/477
(100 %)
1 diff
(99.8 %id)
BE388067 endometrium, adenocarcinoma cell line, uterus .a 1554 to 2158 1 to 608       608/610
(99 %)
8 diff
(98.7 %id)
BQ054892 lymph, lymphoma, cell line .a 1554 to 2246 1 to 697       697/1145
(60 %)
9 diff
(99.3 %id)
BQ063175 lymph, lymphoma, cell line .a 1554 to 2508 1 to 966       966/1019
(94 %)
21 diff
(98.0 %id)
BQ684815 ductal carcinoma, cell line, Pancreas .a 1570 to 2323 1 to 764       764/924
(82 %)
32 diff
(96.6 %id)
BE539137 cervix .a 1575 to 2061 1 to 491       491/661
(74 %)
7 diff
(99.0 %id)
TI_159699135   .a 1576 to 2465 948 to 71       878/1136
(77 %)
26 diff
(97.8 %id)
BU189533 eye, retinoblastoma .a 1596 to 2331 1 to 748       748/899
(83 %)
18 diff
(98.0 %id)
BX366934   .a 1597 to 2425 827 to 1       827/827
(100 %)
16 diff
(98.1 %id)
AL581566 B cells (Ramos cell line), B cells from Burkitt lymphoma .a 1607 to 2427 834 to 17       818/834
(98 %)
3 diff
(99.7 %id)
TI_159701618   .a 1608 to 2465 921 to 75       847/1097
(77 %)
23 diff
(98.0 %id)
BX464574 B cells (Ramos cell line) .a 1614 to 2467 851 to 1       851/851
(100 %)
18 diff
(97.9 %id)
BQ646891 hepatocellular carcinoma, cell line, Liver .a 1622 to 2187 70 to 637       568/1298
(43 %)
16 diff
(98.8 %id)
BQ652285 hepatocellular carcinoma, cell line, Liver .a 1622 to 2482 9 to 869       861/988
(87 %)
12 diff
(98.8 %id)
BQ649771 hepatocellular carcinoma, cell line, Liver .a 1632 to 2482 1 to 857       857/934
(91 %)
10 diff
(99.0 %id)
BQ645148 hepatocellular carcinoma, cell line, Liver .a 1632 to 2446 1 to 818       818/957
(85 %)
8 diff
(99.2 %id)
BQ649937 hepatocellular carcinoma, cell line, Liver .a 1632 to 2456 1 to 834       834/919
(90 %)
31 diff
(96.7 %id)
BQ647212 hepatocellular carcinoma, cell line, Liver .a 1632 to 2482 1 to 857       857/920
(93 %)
15 diff
(98.4 %id)
BQ647480 hepatocellular carcinoma, cell line, Liver .a 1632 to 2162 1 to 538       538/1212
(44 %)
19 diff
(98.5 %id)
BQ652445 hepatocellular carcinoma, cell line, Liver .a 1632 to 2482 1 to 859       859/956
(89 %)
40 diff
(95.9 %id)
BQ647760 hepatocellular carcinoma, cell line, Liver .a 1632 to 2482 1 to 867       867/904
(95 %)
27 diff
(97.1 %id)
BX330946   .a 1646 to 2476 851 to 6       845/914
(92 %)
17 diff
(98.2 %id)
BX355022 Neuroblastoma Cot 25-normalized .a 1657 to 2443 786 to 1       786/786
(100 %)
7 diff
(99.2 %id)
BQ049617 lymph, lymphoma, cell line .a 1681 to 2405 1 to 733       733/1009
(72 %)
61 diff
(94.0 %id)
BX332413 Neuroblastoma Cot 25-normalized .a 1703 to 2454 751 to 1   fully sequenced,   751/751
(100 %)
9 diff
(98.9 %id)
CR596577 B cells (Ramos cell line) Cot 25-normalized .a 1705 to 2484 1 to 780       780/780
(100 %)
0 diff
(100 %id)
CR613412 Neuroblastoma Cot 25-normalized .a 1705 to 2481 1 to 777       777/777
(100 %)
0 diff
(100 %id)
BX353785 Neuroblastoma Cot 25-normalized .a 1705 to 2481 1 to 777       777/777
(100 %)
5 diff
(99.4 %id)
BX401885   .a 1705 to 2484 1 to 781       781/781
(100 %)
1 diff
(99.9 %id)
BF346154 anaplastic oligodendroglioma with 1p/19qloss, brain .a 1706 to 2548 10 to 845       836/1061
(78 %)
34 diff
(96.8 %id)
TI_159693840   .a 1726 to 2460 773 to 49       725/1028
(70 %)
17 diff
(98.4 %id)
BX413975 B cells (Ramos cell line) .a 1727 to 2480 763 to 1       763/923
(82 %)
29 diff
(96.9 %id)
BX413951 B cells (Ramos cell line) .a 1728 to 2475 758 to 6       753/956
(78 %)
18 diff
(98.2 %id)
AL578606 placenta .a 1728 to 2376 722 to 68       655/836
(78 %)
17 diff
(98.0 %id)
BX435802 B cells (Ramos cell line) .a 1737 to 2475 747 to 6       742/921
(80 %)
15 diff
(98.4 %id)
BG391109 embryonal carcinoma, cell line, testis .a 1738 to 2252 1 to 519       519/519
(100 %)
8 diff
(98.5 %id)
BG745159 blood, natural killer cells, cell line .a 1756 to 2430 675 to 1   fully sequenced,   675/675
(100 %)
4 diff
(99.5 %id)
BX383644   .a 1759 to 2421 683 to 19       665/842
(78 %)
20 diff
(97.7 %id)
BE797261 lung, small cell carcinoma .a 1762 to 2568 1 to 804       804/804
(100 %)
10 diff
(98.8 %id)
BX372900 Neuroblastoma Cot 25-normalized .a 1774 to 2443 685 to 7       679/728
(93 %)
28 diff
(96.2 %id)
AL516573 brain, neuroblastoma, neuroblastoma cells .a 1793 to 2457 667 to 1       665/667
(99 %)
22 diff
(96.8 %id)
BU957171 adenocarcinoma, cell line, breast .a 1800 to 2482 1 to 688       688/959
(71 %)
16 diff
(98.4 %id)
CA432508 cell lines, Chondrosarcoma .a 1815 to 2482 686 to 19   AAA   668/668
(100 %)
0 diff
(100 %id)
CX871129 embryonic stem .a 1831 to 2572 1 to 742       742/742
(100 %)
1 diff
(99.9 %id)
CF140023 CNCAP(3)T-225 cell line, Prostate .a 1841 to 2339 1 to 499       499/499
(100 %)
6 diff
(98.8 %id)
TI_154170373   .a 1848 to 2518 78 to 756       679/992
(68 %)
22 diff
(97.8 %id)
BE396088 endometrium, adenocarcinoma cell line, uterus .a 1858 to 2482 1 to 625       625/649
(96 %)
5 diff
(99.3 %id)
BU629552 cell lines, Chondrosarcoma .a 1860 to 2483 642 to 19   AAA   624/625
(99 %)
0 diff
(100 %id)
BQ053454 blood, natural killer cells, cell line .a 1871 to 2482 1 to 612   AAA   612/612
(100 %)
0 diff
(100 %id)
BU623216 cell lines, Chondrosarcoma .a 1882 to 2482 619 to 19   AAA   601/601
(100 %)
3 diff
(99.6 %id)
CA423154 cell lines, Chondrosarcoma .a 1890 to 2483 612 to 19   AAA   594/594
(100 %)
1 diff
(99.9 %id)
CA422735 cell lines, Chondrosarcoma .a 1890 to 2482 611 to 19   AAA   593/593
(100 %)
0 diff
(100 %id)
BG391336 embryonal carcinoma, cell line, testis .a 1895 to 2483 1 to 590   AAA   590/590
(100 %)
2 diff
(99.7 %id)
BG391256 embryonal carcinoma, cell line, testis .a 1896 to 2483 1 to 588   AAA   588/588
(100 %)
1 diff
(99.9 %id)
BX329721 Neuroblastoma Cot 25-normalized .a 1930 to 2482 559 to 1       559/604
(92 %)
32 diff
(94.8 %id)
AI692892 pooled .a 1949 to 2484 539 to 4       536/539
(99 %)
0 diff
(100 %id)
BX404963 B cells (Ramos cell line) .a 1952 to 2448 508 to 1       506/890
(56 %)
23 diff
(97.5 %id)
AW444533   .a 1976 to 2481 517 to 12   AAA   506/506
(100 %)
3 diff
(99.5 %id)
BG034122 breast, mammary adenocarcinoma, cell line .a 1978 to 2744 1 to 778       778/902
(86 %)
13 diff
(98.6 %id)
BE264419 lung, small cell carcinoma .a 1988 to 2552 1 to 565       565/566
(99 %)
1 diff
(99.9 %id)
CX761351 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 2011 to 2648 1 to 637     Submitted on the opposite strand 637/764
(83 %)
2 diff
(99.8 %id)
AW469193 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 2053 to 2484 440 to 9       432/440
(98 %)
0 diff
(100 %id)
BM472234 embryonal carcinoma, cell line, testis .a 2062 to 2484 1 to 423       423/424
(99 %)
1 diff
(99.8 %id)
AA806956 germinal center B cell .a 2064 to 2475 426 to 20       407/426
(95 %)
0 diff
(100 %id)
AA768390 germinal center B cell .a 2072 to 2483 423 to 13   AAA   411/411
(100 %)
3 diff
(99.3 %id)
BG389355 embryonal carcinoma, cell line, testis .a 2084 to 2874 8 to 793       786/805
(97 %)
20 diff
(97.6 %id)
CR614189 HeLa cells Cot 25-normalized .a 2094 to 2484 1 to 391       391/391
(100 %)
0 diff
(100 %id)
BX383903   .a 2094 to 2484 1 to 391   fully sequenced,   391/391
(100 %)
2 diff
(99.5 %id)
BF969154 adrenal cortex carcinoma, cell line, adrenal gland .a 2096 to 2876 1 to 774       774/835
(92 %)
12 diff
(98.6 %id)
AL579157 T cells (Jurkat cell line), T cells from T cell leukemia .a 2109 to 3195 1068 to 1       1068/1081
(98 %)
34 diff
(96.9 %id)
CD632890   .a 2137 to 2483 345 to 2       344/363
(94 %)
0 diff
(100 %id)
CD632891   .a 2137 to 2483 17 to 362       346/362
(95 %)
6 diff
(98.4 %id)
BI224912 Burkitt lymphoma, lymph .a 2144 to 2483 1 to 340   AAA   340/340
(100 %)
1 diff
(99.8 %id)
BX375647 Neuroblastoma Cot 25-normalized .a 2179 to 2484 1 to 306       306/306
(100 %)
1 diff
(99.7 %id)
AI275191 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 2181 to 2484 308 to 6       303/308
(98 %)
0 diff
(100 %id)
AI739449 colon, colon tumor, RER+ .a 2183 to 2483 301 to 1       301/301
(100 %)
2 diff
(99.4 %id)
BI255467 cervical carcinoma cell line, cervix .a 2194 to 2483 24 to 312   AAA   289/312
(92 %)
6 diff
(98.1 %id)
BF001657 colon, colon tumor, RER+ .a 2205 to 2484 286 to 7       280/286
(97 %)
0 diff
(100 %id)
BF002449 colon, colon tumor, RER+ .a 2205 to 2482 282 to 5       278/282
(98 %)
0 diff
(100 %id)
AA159048 Pancreas .a 2221 to 2482 261 to 1       261/263
(99 %)
13 diff
(95.1 %id)
BX447573 B cells (Ramos cell line) .a 2232 to 3215 982 to 1       982/982
(100 %)
3 diff
(99.7 %id)
BX331959 Neuroblastoma Cot 25-normalized .a 2239 to 2483 1 to 245       245/245
(100 %)
6 diff
(97.6 %id)
BX383902   .a 2240 to 2443 210 to 7   fully sequenced,   204/210
(97 %)
4 diff
(98.1 %id)
BU857867 adenocarcinoma, cell line, breast .a 2268 to 3054 1 to 790       790/949
(83 %)
12 diff
(98.8 %id)
BX363163   .a 2281 to 2482 1 to 202       202/202
(100 %)
1 diff
(99.6 %id)
BX400853   .a 2333 to 3179 844 to 1       844/847
(99 %)
4 diff
(99.6 %id)
AI872096 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 2335 to 2483 160 to 12   AAA   149/149
(100 %)
0 diff
(100 %id)
BF792039 adrenal cortex carcinoma, cell line, adrenal gland .a 2596 to 3232 1 to 635       635/651
(97 %)
7 diff
(99.0 %id)
BF795016 lymph, lymphoma, cell line .a 2614 to 3231 1 to 618       618/640
(96 %)
16 diff
(97.5 %id)
BE301693 cervical carcinoma cell line, cervix .a 2803 to 3231 440 to 12   AAA   429/429
(100 %)
0 diff
(100 %id)
DB537351 hippocampus .a 2814 to 3228 1 to 423     Submitted on the opposite strand 423/423
(100 %)
18 diff
(95.8 %id)
BE301411 cervical carcinoma cell line, cervix .a 2839 to 3233 406 to 12   AAA   395/395
(100 %)
2 diff
(99.5 %id)
BU179448 hepatocellular carcinoma, cell line, Liver .a 2848 to 3228 1 to 382   AAA   382/382
(100 %)
1 diff
(99.8 %id)
BQ646248 hepatocellular carcinoma, cell line, Liver .a 2848 to 3228 1 to 382   AAA   382/382
(100 %)
1 diff
(99.8 %id)
BX329393 Neuroblastoma Cot 25-normalized .a 2871 to 3231 356 to 1     Submitted on the opposite strand 356/924
(38 %)
7 diff
(99.3 %id)
AI699664 thymus, pooled .a 2947 to 3232 287 to 1       287/289
(99 %)
2 diff
(99.4 %id)
AI341582 pooled germ cell tumors .a 2961 to 3228 295 to 28   AAA   268/268
(100 %)
3 diff
(98.9 %id)
AW024110 pooled germ cell tumors .a 2964 to 3232 269 to 1       269/404
(66 %)
0 diff
(100 %id)
AW590274 pooled germ cell tumors .a 2964 to 3230 269 to 3       267/413
(64 %)
0 diff
(100 %id)
BF061880 pooled germ cell tumors .a 2964 to 3232 269 to 1       269/491
(54 %)
0 diff
(100 %id)
AI766474 colon, colon tumor, RER+ .a 2974 to 3234 270 to 6   tiling clone,   265/272
(97 %)
0 diff
(100 %id)
BG204521   .a 3036 to 3232 1 to 193       193/205
(94 %)
8 diff
(96.1 %id)
AA534972 colon .a 3037 to 3232 195 to 1       195/195
(100 %)
2 diff
(99.0 %id)
AA524324 colon .a 3037 to 3232 194 to 1       194/194
(100 %)
7 diff
(96.4 %id)
BG218233   .a 3041 to 3232 3 to 193       191/205
(93 %)
3 diff
(98.6 %id)
BG198856   .a 3053 to 3232 16 to 194       179/206
(86 %)
4 diff
(98.1 %id)
AW236572 pooled germ cell tumors .a 3055 to 3229 179 to 5       175/179
(97 %)
0 diff
(100 %id)
AW275033 pooled germ cell tumors .a 3055 to 3229 179 to 5       175/179
(97 %)
0 diff
(100 %id)
BE502560 pooled germ cell tumors .a 3055 to 3228 191 to 18   AAA   174/174
(100 %)
0 diff
(100 %id)
TI_57240854   .b 1 to 859 29 to 900 P2S Q183T M184D T185D R186A ... tiling clone,   872/902
(96 %)
26 diff
(97.2 %id)
BI914583 brain .b 7 to 577 1 to 572       572/572
(100 %)
1 diff
(99.9 %id)
CN368714 embryonic stem cells, DMSO-treated H9 cellline .c-u 1 to 619 1 to 619 exact tiling clone,   619/626
(98 %)
1 diff
(99.9 %id)
BG912833 anaplastic oligodendroglioma with 1p/19qloss, brain .c-u 255 to 936 1 to 683   tiling clone,   683/684
(99 %)
10 diff
(98.6 %id)
BE379308 endometrium, adenocarcinoma cell line, uterus .c-u 320 to 927 5 to 612   tiling clone,   608/612
(99 %)
6 diff
(99.1 %id)
BX405983 fetal liver, Liver Gene CDT1, variant not shown       fully sequenced, Suspected internal deletion, this clone was ignored    
BX405984 fetal liver, Liver Gene CDT1, variant not shown       fully sequenced, Suspected internal deletion, this clone was ignored    
CA337231 posterior rhombomeres 5-8 (4 pooled) Gene CDT1, variant not shown         Suspected internal deletion, this clone was ignored    
BM695575 eye, optic nerve Gene CDT1, variant not shown         This clone was ignored    
BU728985 eye, optic nerve Gene CDT1, variant not shown       AAA This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI